Cargando…

Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: implications for Parkinson's disease

Degeneration of the locus coeruleus noradrenergic system is thought to play a key role in the pathogenesis of Parkinson's disease (PD), whereas pharmacological approaches to increase noradrenaline bioavailability may provide neuroprotection. Noradrenaline inhibits microglial activation and supp...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Neill, Eoin, Harkin, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108217/ https://www.ncbi.nlm.nih.gov/pubmed/30106035 http://dx.doi.org/10.4103/1673-5374.235219

Ejemplares similares

The Noradrenergic System in Parkinson’s Disease
por: Paredes-Rodriguez, Elena, et al.
Publicado: (2020)

Dopaminergic, serotonergic, and noradrenergic deficits in Parkinson disease
por: Buddhala, Chandana, et al.
Publicado: (2015)

Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
por: Peterson, Andrew C., et al.
Publicado: (2018)

Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy
por: Alarcon-Gil, Jesus, et al.
Publicado: (2022)

Dying-back of ascending noradrenergic projections in Parkinson’s disease
por: Helmich, Rick C, et al.
Publicado: (2021)

Restoration of Noradrenergic Function in Parkinson’s Disease Model Mice
por: Cui, Kui, et al.
Publicado: (2021)

Anti-Inflammatory and Neuroprotective Role of Natural Product Securinine in Activated Glial Cells: Implications for Parkinson's Disease
por: Leonoudakis, Dmitri, et al.
Publicado: (2017)

Anti-Inflammatory and Neuroprotective Effects of Morin in an MPTP-Induced Parkinson’s Disease Model
por: Hong, Dong Geun, et al.
Publicado: (2022)

Secretagogin expression in the vertebrate brainstem with focus on the noradrenergic system and implications for Alzheimer’s disease
por: Zahola, Péter, et al.
Publicado: (2019)

Neuroprotective and Anti-Inflammatory Effects of Evernic Acid in an MPTP-Induced Parkinson’s Disease Model
por: Lee, Seulah, et al.
Publicado: (2021)

α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis
por: Butkovich, Laura M., et al.
Publicado: (2018)

Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes
por: Hezemans, Frank H., et al.
Publicado: (2022)

Targeting immunometabolism as an anti-inflammatory strategy
por: Pålsson-McDermott, Eva M., et al.
Publicado: (2020)

The noradrenergic paradox: implications in the management of depression and anxiety
por: Montoya, Alonso, et al.
Publicado: (2016)

Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease
por: Faust, Katharina, et al.
Publicado: (2009)

Shining light on the noradrenergic system
por: Tanguay, Emmeraude, et al.
Publicado: (2023)

Sleep and Sedative States Induced by Targeting the Histamine and Noradrenergic Systems
por: Yu, Xiao, et al.
Publicado: (2018)

Anti-inflammatory and neuroprotective effects of an orally active apocynin derivative in pre-clinical models of Parkinson’s disease
por: Ghosh, Anamitra, et al.
Publicado: (2012)

Noradrenergic dysfunction in Alzheimer's disease
por: Gannon, Mary, et al.
Publicado: (2015)

Modelling the dopamine and noradrenergic cell loss that occurs in Parkinson's disease and the impact on hippocampal neurogenesis
por: Ermine, Charlotte M., et al.
Publicado: (2018)

New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease
por: David, Michael, et al.
Publicado: (2022)

Parkinson’s Disease: Can Targeting Inflammation Be an Effective Neuroprotective Strategy?
por: Gundersen, Vidar
Publicado: (2021)

Multifunctional Metallothioneins as a Target for Neuroprotection in Parkinson’s Disease
por: Miyazaki, Ikuko, et al.
Publicado: (2023)

Developmental control of noradrenergic system by SLITRK1 and its implications in the pathophysiology of neuropsychiatric disorders
por: Hatayama, Minoru, et al.
Publicado: (2023)

Noradrenergic Regulation of Glial Activation: Molecular Mechanisms and Therapeutic Implications
por: Braun, David, et al.
Publicado: (2014)

Noradrenergic Modulation of Cognition in Health and Disease
por: Borodovitsyna, Olga, et al.
Publicado: (2017)

Noradrenergic therapies for apathy in Alzheimer’s disease?
por: Husain, Masud
Publicado: (2023)

Stimulation of noradrenergic transmission by reboxetine is beneficial for a mouse model of progressive parkinsonism
por: Kreiner, Grzegorz, et al.
Publicado: (2019)

Vagus Nerve Stimulation with Mild Stimulation Intensity Exerts Anti-Inflammatory and Neuroprotective Effects in Parkinson’s Disease Model Rats
por: Kin, Ittetsu, et al.
Publicado: (2021)

Astrocytic Nrf2 Mediates the Neuroprotective and Anti-Inflammatory Effects of Nootkatone in an MPTP-Induced Parkinson’s Disease Mouse Model
por: Park, Jung-Eun, et al.
Publicado: (2023)

Transcription Factor Nrf2: a novel target to modulate inflammatory and neuroprotective responses in Parkinson’s disease
por: Cuadrado, Antonio
Publicado: (2015)

Modulating arousal to overcome gait impairments in Parkinson’s disease: how the noradrenergic system may act as a double-edged sword
por: Tosserams, Anouk, et al.
Publicado: (2023)

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
por: Richardson, Jason R., et al.
Publicado: (2013)

Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson’s Disease
por: Curry, Daniel W., et al.
Publicado: (2018)

Glutamic Acid Transporters: Targets for Neuroprotective Therapies in Parkinson’s Disease
por: Li, Xiang, et al.
Publicado: (2021)

Mitochondrial Metabolism as Target of the Neuroprotective Role of Erythropoietin in Parkinson’s Disease
por: Rey, Federica, et al.
Publicado: (2021)

Restoring Spinal Noradrenergic Inhibitory Tone Attenuates Pain Hypersensitivity in a Rat Model of Parkinson's Disease
por: Cao, Lei-Fang, et al.
Publicado: (2016)

Neurodegeneration and neuroprotection in Parkinson's disease /
Publicado: (1996)

Noradrenergic pathway from the locus coeruleus to heart is implicated in modulating SUDEP
por: Lian, XiTing, et al.
Publicado: (2023)

Pain Modulation from the Locus Coeruleus in a Model of Hydrocephalus: Searching for Oxidative Stress-Induced Noradrenergic Neuroprotection
por: Louçano, Marta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_h0qsqfok58e0tub7hiv209v1a9